165
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Fibrinolytic Therapy of Thrombosis in 27 Newborns Followed-up in Neonatal Intensive Care Unit

, , , , , & show all
Pages 705-716 | Received 07 Mar 2013, Accepted 04 Apr 2013, Published online: 07 May 2013

REFERENCES

  • Manco-Johnson MJ. Controversies in neonatal thrombotic disorders. In: Ohls R, Yoder MC, eds. Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies. Vol. 1. Philadelphia: Saunders Elsevier; 2008:58–74.
  • Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74:415–425.
  • Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939–943.
  • Demirel N, Aydın M, Zenciroğlu A, Neonatal thrombo-embolism: risk factors, clinical features and outcome. Ann Trop Paeditr. 2009;29:271–279.
  • Cheah FC, Boo NY, Rohana J, Yong SC. Successful clot lysis using low dose of streptokinase in 22 neonates with aortic thromboses. J Paediatr Child Health. 2001;37(5):479–482.
  • Nowak-Göttl U, Schwabe D, Schneider W, Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet. 1992;340:1105.
  • Dillon PW, Fox PS, Berg CJ, Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy. J Pediatr Surg. 1993;28:1264–1269.
  • Farnoux C, Camard O, Pinquier D, Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998;133(1):137–140.
  • Aydin B, Dilli D, Uzunaliç N, Calcified thrombosis of the inferior vena cava extending to renal veins in a newborn with homozygous MTHFR a1298c mutation. Genet Couns. 2012;23(4):523–527.
  • Guyatt GH, Akl EA, Crowther M, Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):7S–47S.
  • Kothari SS, Varma S, Wasir HS. Thrombolytic therapy in infants and children. Am Heart J. 1994;127:651–657.
  • Hartmann J, Hussein A, Trowitzsch E, Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed. 2001;85(1):18–22.
  • Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995;108(Suppl):506S–522S.
  • Smets K, Vanhaesebrouck P, Voet D, Use of tissue type plasminogen activator in neonates: case reports and review of the literature. Am J Perinatol. 1996;13(4):217–222.
  • Leaker M, Massicotte MP, Brooker LA. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost. 1996;76:132–134.
  • Zenz W, Muntean W, Beitzke A, Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J. 1993;70:382–385.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.